Just as we saw in osteoarthritis, Wobenzym® protects and preserves joint cartilage significantly better than NSAIDs in rheumatoid arthritis50-60. What other types of arthritis can benefit from using Wobenzym®?
Juvenile chronic arthritis is a group of systemic inflammatory disorders affecting children below the age of 16 years. Because of its inflammatory nature it is often compared to the rheumatoid arthritis seen in adults. It is a relatively rare condition (9 – 25 per 100, 000) which affects girls 2 to 3 times more often than boys. A small study including both boys and girls revealed therapeutic benefits with 4 to 5 months. No side effects were observed. Only two children experienced a relapse in the more than 2 years of follow-up exams. The addition of systemic enzyme support improved both articular signs and extra-articular manifestations in the majority of the children with juvenile chronic arthritis and was able to help limit the use of corticosteroids in some children. Psoriatic arthritis is a type of inflammatory arthritis that affects about 10 to 30% of people who have psoriasis. A small study showed improvement at about 4 months as well. Now what is interesting, is they only used 9
